AzTrials
AzTrials

Pain, AcuteNCT05181371

ESP Block in VATS: Programmed Intermittent Bolus Versus Continuous Infusion on Quality of Recovery

A study testing Ultrasound Guided ESP Block with Programmed Intermittent Bolus (PIB) for VATS and Ultrasound Guided ESP Block with Continuous Infusion (CI) for VATS in people with Pain, Acute and Surgery, run by Mater Misericordiae University Hospital at 2 sites in Ireland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Fascial plane blocks, such as ESP, rely on the spread of local anaesthetic on an interfacial plane, automated boluses may be particularly useful for this group of blocks. However, until recently, ambulatory pumps capable of providing automated boluses in addition to patient-controlled boluses were not widely… Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Pain, Acute, Surgery
What is being tested?
Ultrasound Guided ESP Block with Programmed Intermittent Bolus (PIB) for VATS and Ultrasound Guided ESP Block with Continuous Infusion (CI) for VATS
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesIreland
Study dates
2 Jun 2022to 1 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male and Female aged > 18
  • Able to provide written informed consent
  • ASA grade I - V
  • VATS surgery
  • Weight > 55kg

Who cannot join

  • Absence of or inability to give informed consent
  • Pre-existing infection at block site
  • Severe coagulopathy
  • Allergy to local anaesthesia (or another contraindication to block performance)
  • Previous history of opiate abuse
  • Pre-existing chronic pain condition
Show all 9Show fewer
  • Pre-existing dementia (due to need to co-operate in completing QoR-15 score day after surgery
  • Postoperative admission to ICU for continued ventilation
  • BMI > 40 kg/m2

Trial locations and contacts

2 sites in 1 country.

Ireland2 sites
  • Mater Misericordiae University Hospital

    Dublin, D07 R2WY

  • St Jame's University Hospital

    Dublin, D08 NHy1

Other trials in Ireland

About this study

Official title: Ultrasound Guided, Continuous Erector Spinae Plane (ESP) Block in Minimally Invasive Thoracic Surgery: Comparing Programmed Intermittent Bolus (PIB) vs Continuous Infusion on Quality of Recovery and Postoperative Respiratory Function

Fascial plane blocks, such as ESP, rely on the spread of local anaesthetic on an interfacial plane, automated boluses may be particularly useful for this group of blocks. However, until recently, ambulatory pumps capable of providing automated boluses in addition to patient-controlled boluses were not widely available. To best of our knowledge, there are no randomised controlled trials comparing continuous infusion versus intermittent bolus strategies for Erector Spinae Plane Block for MITS in terms of patient centred outcomes such as quality of recovery.

Read the detailed description

Minimally invasive thoracic surgery (MITS) has been shown to reduce postoperative pain, reduce tissue trauma and contribute to better recovery as compared to open thoracotomy. However, it still causes significant acute post-operative pain. Our Mater research group has shown that fascial plane blocks such as the Erector Spinae Plane block (ESP) contribute to post-operative analgesia after MITS. Case reports have described the improved quality of analgesia following ESP using programmed intermittent boluses (PIB) instead of continuous infusion. It is hypothesised that larger, repeated bolus doses provide superior analgesia, possibly as a result of improved spread of the local anaesthetic. Evidence for improved spread of local anaesthetic may be found in one study which demonstrated that PIB increased the number of affected dermatomal levels compared to continuous infusions for continuous paravertebral blocks. Similarly, with regard to labour epidural analgesia, PIB provides better analgesia compared with continuous infusion.

Because fascial plane blocks, such as ESP, rely on the spread of local anaesthetic on an interfacial plane, automated boluses may be particularly useful for this group of blocks. However, until recently, ambulatory pumps capable of providing automated boluses in addition to patient-controlled boluses were not widely available. To the best of our knowledge, there are no randomised controlled trials comparing continuous infusion versus intermittent bolus strategies for Erector Spinae Plane Block for MITS in terms of patient-centered outcomes such as quality of recovery.

Conditions
Pain, Acute, Surgery
Being tested
Ultrasound Guided ESP Block with Programmed Intermittent Bolus (PIB) for VATS, Ultrasound Guided ESP Block with Continuous Infusion (CI) for VATS
Keywords
Regional Anesthesia, Erector Spinae Block, VATS, Quality of Recovery, Acute pain
Medical subject headings
Acute Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound Guided ESP Block with Programmed Intermittent Bolus (PIB) for VATSProcedure or surgery

    Programmed Intermittent Bolus (PIB) of Levobupivacaine

  • Ultrasound Guided ESP Block with Continuous Infusion (CI) for VATSProcedure or surgery

    Continuous Infusion (CI) of Levobupivacaine

Study groups in NCT05181371
Study groupRoleWhat they receive
Ultrasound Guided ESP Block with Programmed Intermittent Bolus (PIB)Active comparatorAfter induction of general anaesthesia, an ESP catheter will be inserted at the level of T5. A bolus dose of 20 ml 0.25% Levobupicaine will be administered into the ESP space. Two hours post bolus administration, patients will receive programmed intermittent bolus of local anaesthetic: 20mls 0.125% levobupivacaine every two hours.
Receives: Procedure: Ultrasound Guided ESP Block with Programmed Intermittent Bolus (PIB) for VATS
Ultrasound Guided ESP Block with Continuous Infusion (CI)Active comparatorAfter induction of general anaesthesia, an ESP catheter will be inserted at the level of T5. A bolus dose of 20 ml 0.25% Levobupicaine will be administered into the ESP space. Two hours post bolus administration, patients will receive a continuous infusion local anaesthetic: 0.125% levobupivacaine at an infusion rate of 10 ml/hr.
Receives: Procedure: Ultrasound Guided ESP Block with Continuous Infusion (CI) for VATS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of Recovery (QoR-15)

    Patient centred metric to measure the quality of recovery after surgery. Scale is between 0-150, where '0' refers to poor quality of recovery and '150' refers to excellent quality of recovery

    Measured: 24 hours

Secondary outcomes (8)
  1. Maximal inspiratory volume

    This will be measured with a calibrated incentive spirometer at the bedside

    Measured: 48 hours

  2. Area Under the Curve for Verbal Rating Score for pain at rest

    Pain scores (0-10). '0' refers to no pain and '10' refers to severe pain.

    Measured: 48 hours

  3. Area Under the Curve for Verbal Rating Score for pain on deep inspiration

    Pain scores (0-10). '0' refers to no pain and '10' refers to severe pain.

    Measured: 48 hours

  4. Time to first intravenous opioid

    Will be measured from immediate postoperative in minutes

    Measured: 48 hours

  5. Time to first mobilisation

    Will be measured from immediate postoperative in hours

    Measured: 48 hours

  6. Duration of time in PACU .

    Will be measured from immediate postoperative in minutes

    Measured: 24 hours

  7. Length of hospital stay

    Will be measured from immediate postoperative in days

    Measured: 30 days

  8. Quality of Recovery (QoR-15)

    Patient centred metric to measure the quality of recovery after surgery. Scale is between 0-150, where '0' refers to poor quality of recovery and '150' refers to excellent quality of recovery

    Measured: 48 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2022
  2. Study start2 Jun 2022
  3. Primary completion1 Aug 2023
  4. Study completion1 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05181371
Sponsor's protocol ID
ESP2
Status last verified
Sep 2023
First submitted
19 Dec 2021
Last updated
21 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual Patient Data sharing will be supported with qualified external researchers and supporting clinical documents from eligible studies. All data provided will be coded and anonymised to respect the privacy of patients who have participated in the trial.

Publications

  • Finnerty D, Ni Eochagain A, Ahmed M, Poynton A, Butler JS, Buggy DJ. A randomised trial of bilateral erector spinae plane block vs. no block for thoracolumbar decompressive spinal surgery. Anaesthesia. 2021 Nov;76(11):1499-1503. doi: 10.1111/anae.15488. Epub 2021 Apr 20.

    PubMed 33878196
  • Finnerty DT, McMahon A, McNamara JR, Hartigan SD, Griffin M, Buggy DJ. Comparing erector spinae plane block with serratus anterior plane block for minimally invasive thoracic surgery: a randomised clinical trial. Br J Anaesth. 2020 Nov;125(5):802-810. doi: 10.1016/j.bja.2020.06.020. Epub 2020 Jul 11.

    PubMed 32660716
  • Onuoha OC. Epidural Analgesia for Labor: Continuous Infusion Versus Programmed Intermittent Bolus. Anesthesiol Clin. 2017 Mar;35(1):1-14. doi: 10.1016/j.anclin.2016.09.003. Epub 2016 Dec 12.

    PubMed 28131113
  • Ilfeld BM, Gabriel RA. Basal infusion versus intermittent boluses for perineural catheters: should we take the 'continuous' out of 'continuous peripheral nerve blocks'? Reg Anesth Pain Med. 2019 Mar;44(3):285-286. doi: 10.1136/rapm-2018-100262. Epub 2019 Jan 13. No abstract available.

    PubMed 30636717
  • Eochagain AN, Moorthy A, O'Gara A, Buggy DJ. Ultrasound-guided, continuous erector spinae plane (ESP) block in minimally invasive thoracic surgery-comparing programmed intermittent bolus (PIB) vs continuous infusion on quality of recovery and postoperative respiratory function: a double-blinded randomised controlled trial. Trials. 2022 Sep 21;23(1):792. doi: 10.1186/s13063-022-06726-7.

    PubMed 36131308

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound Guided ESP Block with Programmed Intermittent Bolus (PIB) for VATS and Ultrasound Guided ESP Block with Continuous Infusion (CI) for VATS in people with Pain, Acute and Surgery, run by Mater Misericordiae University Hospital at 2 sites in Ireland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of Recovery (QoR-15) (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05181371, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in